Nanostructured Lipid Carrier–Mediated Transdermal Delivery of Aceclofenac Hydrogel Present an Effective Therapeutic Approach for Inflammatory Diseases

Aceclofenac (ACE), a cyclooxygenase-2 inhibitor, is the derivative of the diclofenac group that has been in use for the symptomatic treatment of systemic inflammatory autoimmune disease, rheumatoid arthritis (RA). Partial solubility, high lipophilic nature, and stability challenge its use in develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Garg, Neeraj K., Tandel, Nikunj, Bhadada, Sanjay Kumar, Tyagi, Rajeev K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488093/
https://www.ncbi.nlm.nih.gov/pubmed/34616297
http://dx.doi.org/10.3389/fphar.2021.713616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488093/
https://www.ncbi.nlm.nih.gov/pubmed/34616297
http://dx.doi.org/10.3389/fphar.2021.713616

Ejemplares similares